Taconic Biosciences Expands Humanized Mouse Model Production
February 14, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces its humanized immune system mice models are now...
Taconic Biosciences Launches New Immuno-oncology Mouse Model
January 31, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Jan. 31, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the...
Taconic Biosciences Announces New San Diego Location
January 02, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the availability of both commercial animal...
Taconic Biosciences Announces New Scientific Advisory Board Member
October 17, 2019 09:44 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the addition of Frank Sistare, PhD to its...
Taconic Biosciences is First and Only Animal Vendor to Announce All Commercial Mouse Colonies Free of New Pathogen
June 03, 2019 10:08 ET
|
Taconic Biosciences
RENSSELAER, N.Y., June 03, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces that all commercial mouse colonies and...
Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases
April 01, 2019 11:43 ET
|
Taconic Biosciences
RENSSELAER, N.Y., April 01, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild...
Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences
January 31, 2019 10:01 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences’ Board of Directors has selected Nancy J. Sandy to succeed Dr. Robert J. Rosenthal as Chief Executive Officer (CEO). Effective...
UPDATE— Taconic Biosciences Becomes the First Animal Model Provider on General Services Administration Contract Schedule
September 20, 2018 12:07 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces a new relationship with Government...
Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership
July 18, 2018 08:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated...
타코닉 바이오사이언스, 식이유도비만 모델 유럽 생산 개시
June 14, 2018 01:04 ET
|
Taconic Biosciences
미국 뉴욕주 렌셀러, June 14, 2018 (GLOBE NEWSWIRE) -- 유전자 변형 마우스 모델 및 서비스 솔루션 제공 업계의 글로벌 선두주자인 타코닉 바이오사이언스(Taconic Biosciences)가 타코닉 식이유도비만(DIO) 모델의 유럽 현지 생산을 개시한다고 발표했다. DIO 마우스는 포도당, 인슐린, 콜레스테롤, 렙틴,...